DHX9 as a prognostic biomarker and its biological roles in acute myeloid leukemia

Abstract Background Acute myeloid leukemia (AML) is a highly malignant hematopoietic disease, with low remission and high relapse rates, and there is currently no effective treatment except for acute promyelocytic leukemia. DExH-Box Helicase 9, a member of the DExD/H-box family of helicases, is high...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Yacen Xiong, Yan Chen, Huixin Luo, Minhui Shi, Chong Wang, Xueyang Hu, Huaiping Zhu
Format:	Article
Language:	English
Published:	BMC 2025-09-01
Subjects:	Acute myeloid leukemia DExH-Box helicase 9 Biomarker Proliferation Apoptosis
Online Access:	https://doi.org/10.1186/s12885-025-14708-6